Overview
Location
United States, California, San Jose
Employees
1-10
Phone
+1 408-708-9808
Founded date
1982
Mentions in press and media 17
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 8, 2023 | An end to breast cancer? California company develops groundbreaking vaccine with promising future | San Jose company behind vaccine that could eradicate breast cancer San Jose company behind vaccine that could eradicate breast cancer 02:41 SACRAMENTO -- An estimated one in eight women will develop breast cancer in their lifetime, killing ... |
| Apr 17, 2023 | Anixa Biosciences Clarifies Poster Presentation on Company Website | SAN JOSE, Calif., April 17, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ANIX, a biotechnology company focused on the treatment and prevention of cancer today announced that a technical error was made by the company's website hosting servic... |
| Aug 1, 2022 | Slone Partners Places Thomas Schlumpberger as Chief Executive Officer at Nanomix | “Thomas Schlumpberger is an experienced and admired leader in the POC diagnostics field where he has achieved extraordinary success in every management role,” said Slone Partners President Tara Kochis. SOUTH RIDING, Va. (PRWEB) August 01, 2... |
| Jan 25, 2022 | Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine | SAN JOSE, Calif., Jan. 25, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that the Japanese Patent Office has i... |
| Oct 6, 2021 | Anixa Biosciences : Announces First Chinese Patent on its CAR-T Cancer Therapy Technology | SAN JOSE, Calif., Oct. 6, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa"), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the China Nat... |
| Oct 1, 2021 | Anixa Biosciences : Announces Notice of Allowance for Additional Patent on its CAR-T Cancer Therapy | SAN JOSE, Calif., Oct. 1, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa"), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the U.S. Pate... |
| Aug 18, 2021 | Anixa Biosciences : Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology | SAN JOSE, Calif., Aug. 18, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the U.S. Patent and Trademark Of... |
| Aug 18, 2021 | Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology | |
| May 26, 2021 | ANIXA BIOSCIENCES, INC. Anixa Biosciences : Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic | SAN JOSE, Calif., May 26, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that its ovarian cancer vaccine techno... |
Show more
Reviews 0
FAQ about Anixa Biosciences, Inc.
When was Anixa Biosciences, Inc. founded?
Anixa Biosciences, Inc. was founded in 1982.
What has the press written about Anixa Biosciences, Inc.?
Parsers VC has collected 17 articles mentioning Anixa Biosciences, Inc., among them “An end to breast cancer? California company develops groundbreaking vaccine with promising future” (Dec 8, 2023) and “Anixa Biosciences Clarifies Poster Presentation on Company Website” (Apr 17, 2023).
Is Anixa Biosciences, Inc. still active?
Yes, Anixa Biosciences, Inc. is active; its latest activity on Parsers VC dates from Sep 24, 2026.